166 related articles for article (PubMed ID: 27965516)
1. New aminoglycoside-modifying enzymes APH(3')-VIII and APH(3')-IX in Acinetobacter rudis and Acinetobacter gerneri.
Yoon EJ; Grillot-Courvalin C; Courvalin P
J Antibiot (Tokyo); 2017 Apr; 70(4):400-403. PubMed ID: 27965516
[TBL] [Abstract][Full Text] [Related]
2. Origin in Acinetobacter guillouiae and dissemination of the aminoglycoside-modifying enzyme Aph(3')-VI.
Yoon EJ; Goussard S; Touchon M; Krizova L; Cerqueira G; Murphy C; Lambert T; Grillot-Courvalin C; Nemec A; Courvalin P
mBio; 2014 Oct; 5(5):e01972-14. PubMed ID: 25336457
[TBL] [Abstract][Full Text] [Related]
3. Cloning and Expression of Novel Aminoglycoside Phosphotransferase Genes from Campylobacter and Their Role in the Resistance to Six Aminoglycosides.
Zhao S; Mukherjee S; Li C; Jones SB; Young S; McDermott PF
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109167
[TBL] [Abstract][Full Text] [Related]
4. Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain.
Fernández-Martínez M; Miró E; Ortega A; Bou G; González-López JJ; Oliver A; Pascual A; Cercenado E; Oteo J; Martínez-Martínez L; Navarro F;
Int J Antimicrob Agents; 2015 Aug; 46(2):157-63. PubMed ID: 26022930
[TBL] [Abstract][Full Text] [Related]
5. Transferable amikacin resistance in Acinetobacter spp. due to a new type of 3'-aminoglycoside phosphotransferase.
Lambert T; Gerbaud G; Courvalin P
Antimicrob Agents Chemother; 1988 Jan; 32(1):15-9. PubMed ID: 2831812
[TBL] [Abstract][Full Text] [Related]
6. High-level amikacin resistance in Escherichia coli due to phosphorylation and impaired aminoglycoside uptake.
Perlin MH; Lerner SA
Antimicrob Agents Chemother; 1986 Feb; 29(2):216-24. PubMed ID: 2424366
[TBL] [Abstract][Full Text] [Related]
7. Frequency of Aminoglycoside-Modifying Enzymes and ArmA Among Different Sequence Groups of Acinetobacter baumannii in Iran.
Hasani A; Sheikhalizadeh V; Ahangarzadeh Rezaee M; Rahmati-Yamchi M; Hasani A; Ghotaslou R; Goli HR
Microb Drug Resist; 2016 Jul; 22(5):347-53. PubMed ID: 26779992
[TBL] [Abstract][Full Text] [Related]
8. The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China.
Xiao Y; Hu Y
Microb Drug Resist; 2012 Feb; 18(1):42-6. PubMed ID: 22066787
[TBL] [Abstract][Full Text] [Related]
9. Structure-guided optimization of protein kinase inhibitors reverses aminoglycoside antibiotic resistance.
Stogios PJ; Spanogiannopoulos P; Evdokimova E; Egorova O; Shakya T; Todorovic N; Capretta A; Wright GD; Savchenko A
Biochem J; 2013 Sep; 454(2):191-200. PubMed ID: 23758273
[TBL] [Abstract][Full Text] [Related]
10. Molecular epidemiology of aminoglycoside resistance in Acinetobacter spp.
Seward RJ; Lambert T; Towner KJ
J Med Microbiol; 1998 May; 47(5):455-62. PubMed ID: 9879947
[TBL] [Abstract][Full Text] [Related]
11. Nucleotide sequence of Acinetobacter baumannii aphA-6 gene: evolutionary and functional implications of sequence homologies with nucleotide-binding proteins, kinases and other aminoglycoside-modifying enzymes.
Martin P; Jullien E; Courvalin P
Mol Microbiol; 1988 Sep; 2(5):615-25. PubMed ID: 2846986
[TBL] [Abstract][Full Text] [Related]
12. Aph(3')-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia.
Okazaki A; Avison MB
Antimicrob Agents Chemother; 2007 Jan; 51(1):359-60. PubMed ID: 17088477
[TBL] [Abstract][Full Text] [Related]
13. Aminoglycoside phosphotransferase-II-mediated amikacin resistance in Escherichia coli.
Bongaerts GP; Kaptijn GM
Antimicrob Agents Chemother; 1981 Sep; 20(3):344-50. PubMed ID: 6272630
[TBL] [Abstract][Full Text] [Related]
14. [Antibacterial activity of aminoglycosides against nosocomial strains of Acinetobacter baumannii isolated between 1990 and 1999].
González G; Ramírez C; Muñoz M
Rev Esp Quimioter; 2000 Dec; 13(4):401-4. PubMed ID: 11498707
[TBL] [Abstract][Full Text] [Related]
15. Directed evolution of aminoglycoside phosphotransferase (3') type IIIa variants that inactivate amikacin but impose significant fitness costs.
Kramer JR; Matsumura I
PLoS One; 2013; 8(10):e76687. PubMed ID: 24204655
[TBL] [Abstract][Full Text] [Related]
16. Dissemination of amikacin resistance gene aphA6 in Acinetobacter spp.
Lambert T; Gerbaud G; Bouvet P; Vieu JF; Courvalin P
Antimicrob Agents Chemother; 1990 Jun; 34(6):1244-8. PubMed ID: 2168146
[TBL] [Abstract][Full Text] [Related]
17. Aminoglycoside-modifying enzymes among clinical isolates of Acinetobacter calcoaceticus subsp. anitratus (Herellea vaginicola): explanation for high-level aminoglycoside resistance.
Murray BE; Moellering RC
Antimicrob Agents Chemother; 1979 Feb; 15(2):190-9. PubMed ID: 426512
[TBL] [Abstract][Full Text] [Related]
18. Diverse aminoglycoside phosphotransferase types conferring aminoglycoside resistance in
Wangkheimayum J; Bhattacharjee M; Das BJ; Singha KM; Chanda DD; Chanda DD; Bhowmik D; Bhattacharjee A
Indian J Med Microbiol; 2019; 37(3):418-422. PubMed ID: 32003343
[TBL] [Abstract][Full Text] [Related]
19. Genetic basis of resistance to aminoglycosides in Acinetobacter spp. and spread of armA in Acinetobacter baumannii sequence group 1 in Korean hospitals.
Cho YJ; Moon DC; Jin JS; Choi CH; Lee YC; Lee JC
Diagn Microbiol Infect Dis; 2009 Jun; 64(2):185-90. PubMed ID: 19361944
[TBL] [Abstract][Full Text] [Related]
20. The COOH terminus of aminoglycoside phosphotransferase (3')-IIIa is critical for antibiotic recognition and resistance.
Thompson PR; Schwartzenhauer J; Hughes DW; Berghuis AM; Wright GD
J Biol Chem; 1999 Oct; 274(43):30697-706. PubMed ID: 10521458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
